Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.53−0.03 (-1.92%)
Close on Nov 17, 2026Market cap $2.00MP/E –Yield –
Can-Fite BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Can-Fite BioPharma's price to book ratio was 0.7× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.6× to 5.6×, with a median of 1.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | +0.1 |
| 2025 | Dec 31, 2025 | 0.6× | −3.0 |
| 2024 | Dec 31, 2024 | 3.7× | +2.3 |
| 2023 | Dec 29, 2023 | 1.3× | −0.4 |
| 2022 | Dec 30, 2022 | 1.7× | −3.9 |
| 2021 | Dec 31, 2021 | 5.6× | +2.9 |
| 2020 | Dec 31, 2020 | 2.7× | +1.4 |
| 2019 | Jul 31, 2019 | 1.3× | −5.1 |
| 2018 | Jul 31, 2018 | 6.4× | +2.9 |
| 2017 | Dec 29, 2017 | 3.5× | – |
See a number that looks wrong?